Heart HealthAHA Issues First Deprescribing Guidance for Heart Patients on Too Many Drugs
Many patients with heart disease take so many medications that the drugs themselves become a health hazard. Despite this being a recognized problem for decades, clinicians have lacked clear guidance on when and how to safely reduce medication burdens. The American Heart Association has now issued a formal scientific statement addressing this gap. It covers the risks of polypharmacy across all ages — from children to older adults — and outlines practical strategies for deprescribing, meaning the deliberate, supervised reduction or stopping of medications. Key strategies include recognizing clinical warning signs, using validated assessment tools, involving patients in shared decision-making, and coordinating across the entire care team. Both heart and non-heart medications are addressed, since both contribute to the problem.
